Early treatment of endometriosis with GnRH-agonists: impact on time to recurrence

By Schindler A.E.   Foertig P.   Kienle E.   Regidor P.A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 93, Iss. 2, 2000-12 ,pp. : 123-125

Elsevier

Access to resources Recommend Favorite

Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART

By Sonntag Barbara   Kiesel Ludwig   Nieschlag Eberhard   Behre Hermann  

Journal of Assisted Reproduction and Genetics, Vol. 22, Iss. 7-8, 2005-08 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study

By Del Gadillo J.C.B.   Siebzehnrubl E.   Dittrich R.   Wildt L.   Lang N.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 102, Iss. 2, 2002-05 ,pp. : 179-183

Elsevier

Access to resources Recommend Favorite

Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, Cetrorelix, and GnRH agonists

By Nikolettos N.   Al-Hasani S.   Felberbaum R.   Demirel L.C.   Riethmuller-Winzen H.   Reissmann T.   Schopper B.   Sturm R.   Diedrich K.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 93, Iss. 1, 2000-11 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite

Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization5

By Leondires M.P.   Escalpes M.   Segars J.H.   Scott R.T.   Miller B.T.  

Fertility and Sterility, Vol. 72, Iss. 6, 1999-12 ,pp. : 1018-1023

Elsevier

Access to resources Recommend Favorite